[Intra-arterial infusion chemotherapy for unresectable or recurrent breast cancer]. 1998

M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
Dept. of Surgery, Miura Hospital.

Epirubicin and 5-FU were administered through an indwelling catheter inserted into the internal mammary artery and/or subclavian artery employing an implantable infusion port system for the treatment of unresectable advanced breast cancer and recurrent breast cancer. Intraarterial infusion chemotherapy proved to be an effective treatment modality for unresectable advanced breast cancer and recurrent breast cancer.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
April 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
August 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
September 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
February 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
August 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
August 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
July 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
May 2000, Annals of oncology : official journal of the European Society for Medical Oncology,
M An, and Y Matsumoto, and T Kishi, and H Terakado, and M Ikawa, and E Hamada, and Y Watanabe, and S Nakasato, and M Murata, and S Takaki, and T Miura, and Y Idezuki, and M Kobayashi
June 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!